Literature DB >> 17905754

Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5'-region are associated with bipolar affective disorder.

Sven Cichon1, Ingeborg Winge, Manuel Mattheisen, Alexander Georgi, Anna Karpushova, Jan Freudenberg, Yun Freudenberg-Hua, Gulia Babadjanova, Ann Van Den Bogaert, Lilia I Abramova, Sofia Kapiletti, Per M Knappskog, Jeffrey McKinney, Wolfgang Maier, Rami Abou Jamra, Thomas G Schulze, Johannes Schumacher, Peter Propping, Marcella Rietschel, Jan Haavik, Markus M Nöthen.   

Abstract

The neurotransmitter serotonin [5-hydroxytryptamine (5-HT)] controls a broad range of biological functions that are disturbed in affective disorder. In the brain, 5-HT production is controlled by tryptophan hydroxylase 2 (TPH2). In order to assess the possible contribution of TPH2 genetic variability to the aetiology of bipolar affective disorder (BPAD), we systematically investigated common and rare genetic variation in the TPH2 gene through a sequential sequencing and SNP-based genotyping approach. Our study sample comprised two cohorts of BPAD from Germany and Russia, totalling 883 patients and 1300 controls. SNPs located in a haplotype block covering the 5' region of the gene as well as a rare, non-synonymous SNP, resulting in a Pro206Ser substitution, showed significant association with bipolar disorder. The odds ratio for the minor allele in the pooled sample was 1.5 (95% CI 1.2-1.9) for rs11178997 (in the 5'-associated haplotype block) and 4.8 (95% CI 1.6-14.8) for rs17110563 encoding the Pro206Ser substitution. Examination of the functional effects of TPH2 Pro206Ser provided evidence for a reduced thermal stability and solubility of the mutated enzyme, suggesting reduced 5-HT production in the brain as a pathophysiological mechanism in BPAD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905754     DOI: 10.1093/hmg/ddm286

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

Review 1.  Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior?

Authors:  Mariana D Plazas-Mayorca; Kent E Vrana
Journal:  J Proteome Res       Date:  2010-09-09       Impact factor: 4.466

Review 2.  Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-03       Impact factor: 3.568

3.  Serotonergic modulation of 'waiting impulsivity' is mediated by the impulsivity phenotype in humans.

Authors:  S Neufang; A Akhrif; C G Herrmann; C Drepper; G A Homola; J Nowak; J Waider; A G Schmitt; K-P Lesch; M Romanos
Journal:  Transl Psychiatry       Date:  2016-11-08       Impact factor: 6.222

Review 4.  Development by environment interactions controlling tryptophan hydroxylase expression.

Authors:  Matthew W Hale; Anantha Shekhar; Christopher A Lowry
Journal:  J Chem Neuroanat       Date:  2011-05-25       Impact factor: 3.052

Review 5.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

6.  TPH2 5'- and 3'-regulatory polymorphisms are differentially associated with HPA axis function and self-injurious behavior in rhesus monkeys.

Authors:  G-L Chen; M A Novak; J S Meyer; B J Kelly; E J Vallender; G M Miller
Journal:  Genes Brain Behav       Date:  2010-01-05       Impact factor: 3.449

7.  Alternative splicing and extensive RNA editing of human TPH2 transcripts.

Authors:  Maik Grohmann; Paul Hammer; Maria Walther; Nils Paulmann; Andreas Büttner; Wolfgang Eisenmenger; Thomas C Baghai; Cornelius Schüle; Rainer Rupprecht; Michael Bader; Brigitta Bondy; Peter Zill; Josef Priller; Diego J Walther
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

8.  Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice.

Authors:  William B Siesser; Benjamin D Sachs; Amy J Ramsey; Tatyana D Sotnikova; Jean-Martin Beaulieu; Xiaodong Zhang; Marc G Caron; Raul R Gainetdinov
Journal:  ACS Chem Neurosci       Date:  2012-10-01       Impact factor: 4.418

9.  High-resolution chromosome ideogram representation of recognized genes for bipolar disorder.

Authors:  Lindsay N Douglas; Austen B McGuire; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2016-04-07       Impact factor: 3.688

10.  Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.

Authors:  Jean-Martin Beaulieu; Xiaodong Zhang; Ramona M Rodriguiz; Tatyana D Sotnikova; Michael J Cools; William C Wetsel; Raul R Gainetdinov; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.